The United States Genetic Diagnostics Market

by Dr. Hsien-Hsien Lei
Posted October 22, 2007 in DNA Testing

| View | Upload your own

On one of my ramblings around the Web today, I came across this set of slides on genetic diagnostics technologies at SlideShare that was part of talks given at Canada’s MaRS Venture Group. The information is a little dated (March 2006 with 2005 data) but there are still many valid points.

Three types of genetic diagnostic applications are defined:

• Phamacogenomic testing – $95 million market value
• Prenatal newborn testing – $335 million market value
• Predisposition and diagnostic testing – $100 million market value

I expect these figures will skyrocket within a few years.

Some of the challenges listed:

• Healthcare providers are not adequately educated
• Healthcare conservatism
• FDA approval

Some of their recommendations:

• Clinician education
• Direct to consumer advertising (or maybe not?!)
• Promote anti-discrimination legislation (such as GINA, the Genetic Information Nondiscrimination Act)

Tags: genetics, genes, dna, MaRS, personalized medicine, pharmacogenomics, genetic testing, dna tests

(5 comments)

RSS feed

5 Comments

Comment by ramunas

2007-10-22 17:54:51

useful information. thanx.

Reply to this comment

Comment by Hsien-Hsien Lei, PhD

2007-10-22 20:31:16

I’m glad you found it interesting too!

Reply to this comment

 

 

Comment by ramunas

2007-10-22 20:38:32

i think that predisposition testing market should exceed prenatal tests in a near future.

Reply to this comment

Comment by Hsien-Hsien Lei, PhD

2007-10-22 21:01:48

That would definitely make sense!

Reply to this comment

 

 

Pingback by What’s on the web? (24 October 2007) « ScienceRoll

2007-10-24 20:28:00

[...] The United States Genetic Diagnostics Market (Eye on DNA) [...]

Reply to this comment

 

Sorry, the comment form is closed at this time.